These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 38779854)
1. Influence of Polygenic Background on the Clinical Presentation of Familial Hypercholesterolemia. Trinder M; Cermakova L; Ruel I; Baass A; Paquette M; Wang J; Kennedy BA; Hegele RA; Genest J; Brunham LR Arterioscler Thromb Vasc Biol; 2024 Jul; 44(7):1683-1693. PubMed ID: 38779854 [TBL] [Abstract][Full Text] [Related]
2. Polygenic risk scores for low-density lipoprotein cholesterol and familial hypercholesterolemia. Nomura A; Sato T; Tada H; Kannon T; Hosomichi K; Tsujiguchi H; Nakamura H; Takamura M; Tajima A; Kawashiri MA J Hum Genet; 2021 Nov; 66(11):1079-1087. PubMed ID: 33967275 [TBL] [Abstract][Full Text] [Related]
3. Polygenic Hyperlipidemias and Coronary Artery Disease Risk. Ripatti P; Rämö JT; Mars NJ; Fu Y; Lin J; Söderlund S; Benner C; Surakka I; Kiiskinen T; Havulinna AS; Palta P; Freimer NB; Widén E; Salomaa V; Tukiainen T; Pirinen M; Palotie A; Taskinen MR; Ripatti S; Circ Genom Precis Med; 2020 Apr; 13(2):e002725. PubMed ID: 32154731 [TBL] [Abstract][Full Text] [Related]
4. Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia. Sharifi M; Higginson E; Bos S; Gallivan A; Harvey D; Li KW; Abeysekera A; Haddon A; Ashby H; Shipman KE; Cooper JA; Futema M; Roeters van Lennep JE; Sijbrands EJG; Labib M; Nair D; Humphries SE Atherosclerosis; 2017 Aug; 263():405-411. PubMed ID: 28549500 [TBL] [Abstract][Full Text] [Related]
5. Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long-Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events. D'Erasmo L; Minicocci I; Di Costanzo A; Pigna G; Commodari D; Ceci F; Montali A; Brancato F; Stanca I; Nicolucci A; Ascione A; Galea N; Carbone I; Francone M; Maranghi M; Arca M J Am Heart Assoc; 2021 May; 10(9):e018932. PubMed ID: 33890476 [TBL] [Abstract][Full Text] [Related]
6. Assessment of practical applicability and clinical relevance of a commonly used LDL-C polygenic score in patients with severe hypercholesterolemia. Tromp TR; Cupido AJ; Reeskamp LF; Stroes ESG; Hovingh GK; Defesche JC; Schmidt AF; Zuurbier L Atherosclerosis; 2022 Jan; 340():61-67. PubMed ID: 34774301 [TBL] [Abstract][Full Text] [Related]
7. Association of Monogenic vs Polygenic Hypercholesterolemia With Risk of Atherosclerotic Cardiovascular Disease. Trinder M; Francis GA; Brunham LR JAMA Cardiol; 2020 Apr; 5(4):390-399. PubMed ID: 32049305 [TBL] [Abstract][Full Text] [Related]
8. Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia. Chan DC; Pang J; Hooper AJ; Burnett JR; Bell DA; Bates TR; van Bockxmeer FM; Watts GF Int J Cardiol; 2015 Dec; 201():633-8. PubMed ID: 26340131 [TBL] [Abstract][Full Text] [Related]
9. Polygenic Risk Score for Low-Density Lipoprotein Cholesterol Is Associated With Risk of Ischemic Heart Disease and Enriches for Individuals With Familial Hypercholesterolemia. Wu H; Forgetta V; Zhou S; Bhatnagar SR; Paré G; Richards JB Circ Genom Precis Med; 2021 Feb; 14(1):e003106. PubMed ID: 33440130 [TBL] [Abstract][Full Text] [Related]
10. Polygenic Contribution to Low-Density Lipoprotein Cholesterol Levels and Cardiovascular Risk in Monogenic Familial Hypercholesterolemia. Trinder M; Paquette M; Cermakova L; Ban MR; Hegele RA; Baass A; Brunham LR Circ Genom Precis Med; 2020 Oct; 13(5):515-523. PubMed ID: 33079599 [TBL] [Abstract][Full Text] [Related]
11. The different relations of PCSK9 and Lp(a) to the presence and severity of atherosclerotic lesions in patients with familial hypercholesterolemia. Cao YX; Liu HH; Sun D; Jin JL; Xu RX; Guo YL; Wu NQ; Zhu CG; Li S; Zhang Y; Sun J; Li JJ Atherosclerosis; 2018 Oct; 277():7-14. PubMed ID: 30170223 [TBL] [Abstract][Full Text] [Related]
12. Familial Hypercholesterolemia, Familial Combined Hyperlipidemia, and Elevated Lipoprotein(a) in Patients With Premature Coronary Artery Disease. Vikulova DN; Trinder M; Mancini GBJ; Pimstone SN; Brunham LR Can J Cardiol; 2021 Nov; 37(11):1733-1742. PubMed ID: 34455025 [TBL] [Abstract][Full Text] [Related]
13. Relationship of Familial Hypercholesterolemia and High Low-Density Lipoprotein Cholesterol to Ischemic Stroke: Copenhagen General Population Study. Beheshti S; Madsen CM; Varbo A; Benn M; Nordestgaard BG Circulation; 2018 Aug; 138(6):578-589. PubMed ID: 29593013 [TBL] [Abstract][Full Text] [Related]
14. Familial Hypercholesterolemia Genetic Variations and Long-Term Cardiovascular Outcomes in Patients with Hypercholesterolemia Who Underwent Coronary Angiography. Lee WJ; Chuang HN; Chen YM; Liang KW; Tung H; Chen JP; Lee IT; Wang JS; Lin CH; Lin HJ; Sheu WH; Lee WL; Hsiao TH Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573395 [TBL] [Abstract][Full Text] [Related]
15. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry. deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694 [TBL] [Abstract][Full Text] [Related]
16. Significance of lipoprotein(a) levels in familial hypercholesterolemia and coronary artery disease. Li S; Wu NQ; Zhu CG; Zhang Y; Guo YL; Gao Y; Li XL; Qing P; Cui CJ; Xu RX; Sun J; Liu G; Dong Q; Li JJ Atherosclerosis; 2017 May; 260():67-74. PubMed ID: 28351002 [TBL] [Abstract][Full Text] [Related]
17. Twelve Variants Polygenic Score for Low-Density Lipoprotein Cholesterol Distribution in a Large Cohort of Patients With Clinically Diagnosed Familial Hypercholesterolemia With or Without Causative Mutations. Olmastroni E; Gazzotti M; Arca M; Averna M; Pirillo A; Catapano AL; Casula M; J Am Heart Assoc; 2022 Apr; 11(7):e023668. PubMed ID: 35322671 [TBL] [Abstract][Full Text] [Related]
18. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark. Jensen HK Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167 [TBL] [Abstract][Full Text] [Related]
19. Achilles tendon xanthomas are associated with the presence and burden of subclinical coronary atherosclerosis in heterozygous familial hypercholesterolemia: A pilot study. Mangili LC; Miname MH; Silva PRS; Bittencourt MS; Rocha VZ; Mangili OC; Salgado Filho W; Chacra AP; Jannes CE; Pereira AC; Santos RD Atherosclerosis; 2017 Aug; 263():393-397. PubMed ID: 28499609 [TBL] [Abstract][Full Text] [Related]
20. Characteristics and management of 1093 patients with clinical diagnosis of familial hypercholesterolemia in Greece: Data from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH). Rizos CV; Elisaf MS; Skoumas I; Tziomalos K; Kotsis V; Rallidis L; Garoufi A; Athyros VG; Skalidis E; Kolovou G; Koutagiar I; Papagianni M; Antza C; Katsiki N; Ganotakis E; Liberopoulos EN Atherosclerosis; 2018 Oct; 277():308-313. PubMed ID: 30270064 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]